Intravitreal dexamethasone implant for the treatment of macular edema after retinal vein occlusion in a clinical setting

Klinische Monatsblatter fur Augenheilkunde

Volumn 230, Issue 4, 2013, Pages 423-426

  Ferrini, W ^a   Ambresin, A ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

corticosteroids; macular edema; retinal vein occlusion

Indexed keywords

DEXAMETHASONE;

ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HUMAN; MACULAR THICKNESS; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; TONOMETRY; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; DEXAMETHASONE; DRUG IMPLANTS; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; RETINAL VEIN OCCLUSION; TREATMENT OUTCOME; UVEITIS; VISION DISORDERS; VISUAL ACUITY;

EID: 84877003724     PISSN: 00232165     EISSN: 14393999     Source Type: Journal    
DOI: 10.1055/s-0032-1328388     Document Type: Article

References (8)

1. Rogers S., McIntosh R. L., Cheung N. et al. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology: 2010; 117 313 319
2. Noma H., Funatsu H., Yamasaki M. et al. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol: 2005; 140 256 261
3. The Branch Vein Occlusion Study Group Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol: 1984; 98 271 282
4. The Central Vein Occlusion Study Group M report. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. Ophthalmology: 1995; 102 1425 1433
5. Scott I. U., Ip M. S., VanVeldhuisen P. C. et al. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Arch Ophthalmol: 2009; 127 1115 1128
6. Haller J. A., Bandello F., Belfort R. jr. et al. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology: 2010; 117 1134 1146
7. Antonetti D. A., Wolpert E. B., DeMaio L. et al. Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin. J Neurochem: 2002; 80 667 677
8. Chang-Lin J. E., Attar M., Acheampong A. A. et al. Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci: 2011; 52 80 86